Postural hypotension guidline management
"orthostatic hypotension" AND management
orthostatic hypotension management guideline 2024 2025 consensus
https://www.aafp.org/afp/2022/0100/p39
| Option | Typical role | Important precautions |
|---|---|---|
| Midodrine | Often first-line. Alpha-1 agonist that constricts blood vessels. | Can cause supine hypertension, scalp tingling, piloerection, urinary retention. Do not take within 3 to 5 hours of bedtime. |
| Droxidopa | First-line alternative, especially neurogenic orthostatic hypotension. | Can cause headache, nausea, and supine hypertension. Avoid late-day dosing. |
| Fludrocortisone | Expands circulating volume; sometimes used when low volume is important. | Monitor BP, potassium, oedema, and heart failure. Long-term harms and fluid overload limit use. |
| Pyridostigmine, atomoxetine | Specialist-directed add-on options in selected neurogenic cases. | Choice depends on underlying autonomic physiology and coexisting hypertension. |
Can metalozone cause this
metolazone AND hypotension
metolazone prescribing information hypotension volume depletion electrolyte imbalance